Bridging molecular genetics and biomarkers in Lewy body and related disorders

International Journal of Alzheimer's Disease

Volumn , Issue , 2011, Pages

  Ho, Gilbert J ^a,b   Liang, Willie ^a,b   Waragai, Masaaki ^c   Sekiyama, Kazunari ^c   Masliah, Eliezer ^a   Hashimoto, Makoto ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Center for Memory and Aging   (United States)

^c TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN; BETA SYNUCLEIN; BIOLOGICAL MARKER; CHAPERONE; DJ 1 PROTEIN; GAMMA SYNUCLEIN; GLUCOSYLCERAMIDASE; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; IMIGLUCERASE; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; LEUCINE RICH REPEAT KINASE 2; NEUROFILAMENT PROTEIN; TAU PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

AUTOPHAGY; BRAIN SCINTISCANNING; DIFFUSE LEWY BODY DISEASE; DRUG UPTAKE; GENE MUTATION; GENOMICS; HUMAN; MOLECULAR GENETICS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEOMICS; REVIEW; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 80052650458     PISSN: None     EISSN: 20900252     Source Type: Journal    
DOI: 10.4061/2011/842475     Document Type: Review

References (185)

1. McKeith I. G., Galasko D., Kosaka K., Perry E. K., Dickson D. W., Hansen L. A., Salmon D. P., Lowe J., Mirra S. S., Byrne E. J., Lennox G., Quinn N. P., Edwardson J. A., Ince P. G., Bergeron C., Burns A., Miller B. L., Lovestone S., Collerton D., Jansen E. N. H., Ballard C., De Vos R. A. I., Wilcock G. K., Jellinger K. A., Perry R. H., Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop Neurology 1996 47 5 1113 1124 (Pubitemid 26374873)
2. Merdes A. R., Hansen L. A., Jeste D. V., Galasko D., Hofstetter C. R., Ho G. J., Thal L. J., Corey-Bloom J., Influence of Alzheimer pathology on clinical diagnostic accuracy in dementia with Lewy bodies Neurology 2003 60 10 1586 1590 (Pubitemid 36618082)
3. Weintraub D., Comella C. L., Horn S., Parkinson's diseasePart 3: neuropsychiatric symptoms American Journal of Managed Care 2008 14 2 S59 S69
4. Lippa C. F., Duda J. E., Grossman M., Hurtig H. I., Aarsland D., Boeve B. F., Brooks D. J., Dickson D. W., Dubois B., Emre M., Fahn S., Farmer J. M., Galasko D., Galvin J. E., Goetz C. G., Growdon J. H., Gwinn-Hardy K. A., Hardy J., Heutink P., Iwatsubo T., Kosaka K., Lee V. M. Y., Leverenz J. B., Masliah E., McKeith I. G., Nussbaum R. L., Olanow C. W., Ravina B. M., Singleton A. B., Tanner C. M., Trojanowski J. Q., Wszolek Z. K., DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers Neurology 2007 68 11 812 819 (Pubitemid 46568532)
5. Lippa C. F., Smith T. W., Perry E., Dementia with Lewy bodies: choline acetyltransferase parallels nucleus basalis pathology Journal of Neural Transmission 1999 106 56 525 535 (Pubitemid 29273890)
6. Markesbery W. R., Jicha G. A., Liu H., Schmitt F. A., Lewy body pathology in normal elderly subjects Journal of Neuropathology and Experimental Neurology 2009 68 7 816 822
7. Jicha G. A., Schmitt F. A., Abner E., Nelson P. T., Cooper G. E., Smith C. D., Markesbery W. R., Prodromal clinical manifestations of neuropathologically confirmed Lewy body disease Neurobiology of Aging 2010 31 10 1805 1813
8. Jack C. R. Jr., Knopman D. S., Jagust W. J., Shaw L. M., Aisen P. S., Weiner M. W., Petersen R. C., Trojanowski J. Q., Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade The Lancet Neurology 2010 9 1 119 128
9. Vellas B., Andrieu S., Sampaio C., Wilcock G., Disease-modifying trials in Alzheimer's disease: a European task force consensus The Lancet Neurology 2007 6 1 56 62 (Pubitemid 44880273)
10. Haass C., Selkoe D. J., Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid -peptide Nature Reviews Molecular Cell Biology 2007 8 2 101 112 (Pubitemid 46432529)
11. Harding A. J., Halliday G. M., Cortical Lewy body pathology in the diagnosis of dementia Acta Neuropathologica 2001 102 4 355 363 (Pubitemid 32894706)
12. St George-Hyslop P. H., Molecular genetics of Alzheimer's disease Biological Psychiatry 2000 47 3 183 199 (Pubitemid 30077395)
13. Selkoe D., Kopan R., Notch and Presenilin: regulated intramembrane proteolysis links development and degeneration Annual Review of Neuroscience 2003 26 565 597 (Pubitemid 37064944)
14. Vanderstichele H., Van Kerschaver E., Hesse C., Davidsson P., Buyse M. A., Andreasen N., Minthon L., Wallin A., Blennow K., Vanmechelen E., Standardization of measurement of -amyloid((1-42)) in cerebrospinal fluid and plasma Amyloid 2000 7 4 245 258
15. Parnetti L., Tiraboschi P., Lanari A., Peducci M., Padiglioni C., D'Amore C., Pierguidi L., Tambasco N., Rossi A., Calabresi P., Cerebrospinal fluid biomarkers in Parkinson's disease with dementia and dementia with Lewy bodies Biological Psychiatry 2008 64 10 850 855
16. Spies P. E., Slats D., Sjgren J. M. C., Kremer B. P. H., Verhey F. R. J., Olde Rikkert M. G. M., Verbeek M. M., The cerebrospinal fluid amyloid 42/40 ratio in the differentiation of alzheimer's disease from non-alzheimer's dementia Current Alzheimer Research 2010 7 5 470 476
17. Klunk W. E., Engler H., Nordberg A., Wang Y., Blomqvist G., Holt D. P., Bergstrm M., Savitcheva I., Huang G. F., Estrada S., Ausén B., Debnath M. L., Barletta J., Price J. C., Sandell J., Lopresti B. J., Wall A., Koivisto P., Antoni G., Mathis C. A., Lngstrm B., Imaging brain amyloid in Alzheimer's disease with pittsburgh compound-B Annals of Neurology 2004 55 3 306 319 (Pubitemid 38269583)
18. Rowe C. C., Ng S., Ackermann U., Gong S. J., Pike K., Savage G., Cowie T. F., Dickinson K. L., Maruff P., Darby D., Smith C., Woodward M., Merory J., Tochon-Danguy H., O'Keefe G., Klunk W. E., Mathis C. A., Price J. C., Masters C. L., Villemagne V. L., Imaging -amyloid burden in aging and dementia Neurology 2007 68 20 1718 1725 (Pubitemid 46763260)
19. Gomperts S. N., Rentz D. M., Moran E., Becker J. A., Locascio J. J., Klunk W. E., Mathis C. A., Elmaleh D. R., Shoup T., Fischman A. J., Hyman B. T., Growdon J. H., Johnson K. A., Imaging amyloid deposition in Lewy body diseases Neurology 2008 71 12 903 910
20. Goedert M., Ghetti B., Spillantini M. G., Tau gene mutations in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP17). Their relevance for understanding the neurogenerative process Annals of the New York Academy of Sciences 2000 920 74 83 (Pubitemid 32056554)
21. Munoz D. G., Dickson D. W., Bergeron C., Mackenzie I. R. A., Delacourte A., Zhukareva V., The neuropathology and biochemistry of frontotemporal dementia Annals of Neurology 2003 54 supplement 5 S24 S28
22. Basurto-Islas G., Luna-Muoz J., Guillozet-Bongaarts A. L., Binder L. I., Mena R., Garca-Sierra F., Accumulation of aspartic acid- and glutamic acid -cleaved tau in neurofibrillary tangles correlates with progression in Alzheimer disease Journal of Neuropathology and Experimental Neurology 2008 67 5 470 483 (Pubitemid 351653539)
23. Stoothoff W. H., Johnson G. V. W., Tau phosphorylation: physiological and pathological consequences Biochimica et Biophysica Acta 2005 1739 23 280 297 (Pubitemid 40018545)
24. Arai H., Morikawa Y. I., Higuchi M., Matsui T., Clark C. M., Miura M., Machida N., Lee V. M. Y., Trojanowski J. Q., Sasaki H., Cerebrospinal fluid tau levels in neurodegenerative diseases with distinct tau-related pathology Biochemical and Biophysical Research Communications 1997 236 2 262 264 (Pubitemid 27373280)
25. Parnetti L., Lanari A., Amici S., Gallai V., Vanmechelen E., Hulstaert F., CSF phosphorylated tau is a possible marker for discriminating Alzheimer's disease from dementia with Lewy bodies. Phospho-Tau International Study Group Neurological Sciences 2001 22 1 77 78 (Pubitemid 33622091)
26. Engelborghs S., De Vreese K., Van de Casteele T., Vanderstichele H., Van Everbroeck B., Cras P., Martin J. J., Vanmechelen E., De Deyn P. P., Diagnostic performance of a CSF-biomarker panel in autopsy-confirmed dementia Neurobiology of Aging 2008 29 8 1143 1159 (Pubitemid 351822410)
27. Buerger K., Zinkowski R., Teipel S. J., Tapiola T., Arai H., Blennow K., Andreasen N., Hofmann-Kiefer K., DeBernardis J., Kerkman D., McCulloch C., Kohnken R., Padberg F., Pirttil T., Schapiro M. B., Rapoport S. I., Mller H. J., Davies P., Hampel H., Differential diagnosis of Alzheimer disease with cerebrospinal fluid levels of tau protein phosphorylated at threonine 231 Archives of Neurology 2002 59 8 1267 1272 (Pubitemid 34856379)
28. de Jong D., Jansen R. W. M. M., Pijnenburg Y. A. L., Van Geel W. J. A., Borm G. F., Kremer H. P. H., Verbeek M. M., CSF neurofilament proteins in the differential diagnosis of dementia Journal of Neurology, Neurosurgery and Psychiatry 2007 78 9 936 938 (Pubitemid 47310827)
29. Hampel H., Buerger K., Zinkowski R., Teipel S. J., Goernitz A., Andreasen N., Sjoegren M., DeBernardis J., Kerkman D., Ishiguro K., Ohno H., Vanmechelen E., Vanderstichele H., McCulloch C., Mller H. J., Davies P., Blennow K., Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease: a comparative cerebrospinal fluid study Archives of General Psychiatry 2004 61 1 95 102 (Pubitemid 38044645)
30. Koopman K., Le Bastard N., Martin J. J., Nagels G., De Deyn P. P., Engelborghs S., Improved discrimination of autopsy-confirmed Alzheimer's disease (AD) from non-AD dementias using CSF P-tau(181P) Neurochemistry International 2009 55 4 214 218
31. George J. M., Jin H., Woods W. S., Clayton D. F., Characterization of a novel protein regulated during the critical period for song learning in the zebra finch Neuron 1995 15 2 361 372
32. Alim M. A., Hossain M. S., Arima K., Takeda K., Izumiyama Y., Nakamura M., Kaji H., Shinoda T., Hisanaga S., Uéda K., Tubulin seeds -synuclein fibril formation Journal of Biological Chemistry 2002 277 3 2112 2117 (Pubitemid 34968795)
33. Alim M. A., Ma Q. L., Takeda K., Aizawa T., Matsubara M., Nakamura M., Asada A., Saito T., Kaji H., Yoshii M., Hisanaga S., Uéda K., Demonstration of a role for -synuclein as a functional microtubule-associated protein Journal of Alzheimer's Disease 2004 6 4 435 442 (Pubitemid 39287257)
34. Bonini N. M., Giasson B. I., Snaring the function of -synuclein Cell 2005 123 3 359 361
35. Cooper A. A., Gitler A. D., Cashikar A., Haynes C. M., Hill K. J., Bhullar B., Liu K., Xu K., Strathearn K. E., Liu F., Cao S., Caldwell K. A., Caldwell G. A., Marsischky G., Kolodner R. D., LaBaer J., Rochet J. C., Bonini N. M., Lindquist S., α-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models Science 2006 313 5785 324 328 (Pubitemid 44480951)
36. Liu G., Zhang C., Yin J., Li X., Cheng F., Li Y., Yang H., Uéda K., Chan P., Yu S., α-synuclein is differentially expressed in mitochondria from different rat brain regions and dose-dependently down-regulates complex I activity Neuroscience Letters 2009 454 3 187 192
37. Madine J., Doig A. J., Middleton D. A., A study of the regional effects of -synuclein on the organization and stability of phospholipid bilayers Biochemistry 2006 45 18 5783 5792
38. Zhu M., Qin Z. J., Hu D., Munishkina L. A., Fink A. L., -synuclein can function as an antioxidant preventing oxidation of unsaturated lipid in vesicles Biochemistry 2006 45 26 8135 8142 (Pubitemid 43993234)
39. El-Agnaf O. M. A., Irvine G. B., Aggregation and neurotoxicity of -synuclein and related peptides Biochemical Society Transactions 2002 30 4 559 565 (Pubitemid 35001599)
40. Hurtig H. I., Trojanowski J. Q., Galvin J., Ewbank D., Schmidt M. L., Lee V. M. Y., Clark C. M., Glosser G., Stern M. B., Gollomp S. M., Arnold S. E., Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson's disease Neurology 2000 54 10 1916 1921 (Pubitemid 30327112)
41. Spillantini M. G., Crowther R. A., Jakes R., Hasegawa M., Goedert M., α-synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies Proceedings of the National Academy of Sciences of the United States of America 1998 95 11 6469 6473 (Pubitemid 28249037)
42. Hashimoto M., Hsu L. J., Sisk A., Xia Y., Takeda A., Sundsmo M., Masliah E., Human recombinant NACP/ -synuclein is aggregated and fibrillated in vitro: relevance for Lewy body disease Brain Research 1998 799 2 301 306 (Pubitemid 28351261)
43. Polymeropoulos M. H., Lavedan C., Leroy E., Ide S. E., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R., Stenroos E. S., Chandrasekharappa S., Athanassiadou A., Papapetropoulos T., Johnson W. G., Lazzarini A. M., Duvoisin R. C., Di Iorio G., Golbe L. I., Nussbaum R. L., Mutation in the -synuclein gene identified in families with Parkinson's disease Science 1997 276 5321 2045 2047 (Pubitemid 27443610)
44. Krger R., Kuhn W., Mller T., Woitalla D., Graeber M., Ksel S., Przuntek H., Epplen J. T., Schls L., Riess O., Ala30Pro mutation in the gene encoding -synuclein in Parkinson's disease Nature Genetics 1998 18 2 106 108
45. Golbe L. I., Di Iorio G., Sanges G., Lazzarini A. M., La Sala S., Bonavita V., Duvoisin R. C., Clinical genetic analysis of Parkinson's disease in the Contursi kindred Annals of Neurology 1996 40 5 767 775 (Pubitemid 26415189)
46. Yamaguchi K., Cochran E. J., Murrell J. R., Polymeropoulos M. H., Shannon K. M., Crowther R. A., Goedert M., Ghetti B., Abundant neuritic inclusions and microvacuolar changes in a case of diffuse Lewy body disease with the A53T mutation in the -synuclein gene Acta Neuropathologica 2005 110 3 298 305 (Pubitemid 41430659)
47. Morfis L., Cordato D. J., Dementia with Lewy bodies in an elderly Greek male due to -synuclein gene mutation Journal of Clinical Neuroscience 2006 13 9 942 944 (Pubitemid 44666416)
48. Zarranz J. J., Alegre J., Gmez-Esteban J. C., Lezcano E., Ros R., Ampuero I., Vidal L., Hoenicka J., Rodriguez O., Atarés B., Llorens V., Gomez Tortosa E., Del Ser T., Muoz D. G., De Yebenes J. G., The new mutation, E46K, of -synuclein causes Parkinson and Lewy body dementia Annals of Neurology 2004 55 2 164 173 (Pubitemid 38166992)
49. Singleton A. B., Farrer M., Johnson J., Singleton A., Hague S., Kachergus J., Hulihan M., Peuralinna T., Dutra A., Nussbaum R., Lincoln S., Crawley A., Hanson M., Maraganore D., Adler C., Cookson M. R., Muenter M., Baptista M., Miller D., Blancato J., Hardy J., Gwinn-Hardy K., α-synuclein locus triplication causes Parkinson's disease Science 2003 302 5646 841 (Pubitemid 37339619)
50. Li J., Uversky V. N., Fink A. L., Effect of familial Parkinson's disease point mutations A30P and A53T on the structural properties, aggregation, and fibrillation of human -synuclein Biochemistry 2001 40 38 11604 11613 (Pubitemid 32911305)
51. Tsika E., Moysidou M., Guo J., Cushman M., Gannon P., Sandaltzopoulos R., Giasson B. I., Krainc D., Ischiropoulos H., Mazzulli J. R., Distinct region-specific -synuclein oligomers in A53T transgenic mice: implications for neurodegeneration Journal of Neuroscience 2010 30 9 3409 3418
52. Fredenburg R. A., Rospigliosi C., Meray R. K., Kessler J. C., Lashuel H. A., Eliezer D., Lansbury P. T., The impact of the E46K mutation on the properties of -synuclein in its monomelic and oligomeric states Biochemistry 2007 46 24 7107 7118 (Pubitemid 46973985)
53. Iwai A., Masliah E., Yoshimoto M., Ge N., Flanagan L., De Silva H. A. R., Kittel A., Saitoh T., The precursor protein of non-A component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system Neuron 1995 14 2 467 475
54. Nakajo S., Shioda S., Nakai Y., Nakaya K., Localization of phosphoneuroprotein 14 (PNP 14) and its mRNA expression in rat brain determined by immunocytochemistry and in situ hybridization Molecular Brain Research 1994 27 1 81 86 (Pubitemid 24324092)
55. Hashimoto M., Rockenstein E., Mante M., Mallory M., Masliah E., β-synuclein inhibits α-synuclein aggregation: a possible role as an anti-Parkinsonian factor Neuron 2001 32 2 213 223 (Pubitemid 33030190)
56. Ohtake H., Limprasert P., Fan Y., Onodera O., Kakita A., Takahashi H., Bonner L. T., Tsuang D. W., Murray I. V. J., Lee V. M. Y., Trojanowski J. Q., Ishikawa A., Idezuka J., Murata M., Toda T., Bird T. D., Leverenz J. B., Tsuji S., La Spada A. R., -synuclein gene alterations in dementia with Lewy bodies Neurology 2004 63 5 805 811 (Pubitemid 39297638)
57. Fujita M., Sugama S., Sekiyama K., Sekigawa A., Tsukui T., Nakai M., Waragai M., Takenouchi T., Takamatsu Y., Wei J., Rockenstein E., Laspada A. R., Masliah E., Inoue S., Hashimoto M., A -synuclein mutation linked to dementia produces neurodegeneration when expressed in mouse brain Nature Communications 2010 1 8, article 110
58. Wei J., Fujita M., Nakai M., Waragai M., Watabe K., Akatsu H., Rockenstein E., Masliah E., Hashimoto M., Enhanced lysosomal pathology caused by -synuclein mutants linked to dementia with Lewy bodies Journal of Biological Chemistry 2007 282 39 28904 28914 (Pubitemid 47606052)
59. Buchman V. L., Hunter H. J., Pinon L. G., Persyn, a member of the synuclein family, has a distinct pattern of expression in the developing nervous system Journal of Neuroscience 1998 18 22 9335 9341 (Pubitemid 28512464)
60. Ahmad M., Attoub S., Singh M. N., Martin F. L., El-Agnaf O. M. A., α-synuclein and the progression of cancer Journal of the Federation of American Societies for Experimental Biology 2007 21 13 3419 3430
61. Nishioka K., Wider C., Vilario-Gell C., Soto-Ortolaza A. I., Lincoln S. J., Kachergus J. M., Jasinska-Myga B., Ross O. A., Rajput A., Robinson C. A., Ferman T. J., Wszolek Z. K., Dickson D. W., Farrer M. J., Association of -, -, and -synuclein with diffuse Lewy body disease Archives of Neurology 2010 67 8 970 975
62. Galvin J. E., Uryu K., Lee V. M. Y., Trojanowski J. Q., Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains -, -, and -synuclein Proceedings of the National Academy of Sciences of the United States of America 1999 96 23 13450 13455
63. Ninkina N., Peters O., Millership S., Salem H., van der Putten H., Buchman V. L., α-synucleinopathy: neurodegeneration associated with overexpression of the mouse protein Human Molecular Genetics 2009 18 10 1779 1794
64. Buchman V. L., Adu J., Pinn L. G. P., Ninkina N. N., Davies A. M., Persyn, a member of the synuclein family, influences neurofilament network integrity Nature Neuroscience 1998 1 2 101 103
65. El-Agnaf O. M., Salem S. A., Paleologou K. E., Alpha-synuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasma Journal of the Federation of American Societies for Experimental Biology 2003 17 13 1945 1947
66. Lee H. J., Patel S., Lee S. J., Intravesicular localization and exocytosis of -synuclein and its aggregates Journal of Neuroscience 2005 25 25 6016 6024 (Pubitemid 40911433)
67. Desplats P., Lee H. J., Bae E. J., Patrick C., Rockenstein E., Crews L., Spencer B., Masliah E., Lee S. J., Inclusion formation and neuronal cell death through neuron-to-neuron transmission of -synuclein Proceedings of the National Academy of Sciences of the United States of America 2009 106 31 13010 13015
68. Sung J. Y., Park S. M., Lee C. H., Um J. W., Lee H. J., Kim J., Oh Y. J., Lee S. T., Paik S. R., Chung K. C., Proteolytic cleavage of extracellular secreted -synuclein via matrix metalloproteinases Journal of Biological Chemistry 2005 280 26 25216 25224 (Pubitemid 40934615)
69. Borghi R., Marchese R., Negro A., Marinelli L., Forloni G., Zaccheo D., Abbruzzese G., Tabaton M., Full length -synuclein is present in cerebrospinal fluid from Parkinson's disease and normal subjects Neuroscience Letters 2000 287 1 65 67 (Pubitemid 30332379)
70. Mollenhauer B., Cullen V., Kahn I., Krastins B., Outeiro T. F., Pepivani I., Ng J., Schulz-Schaeffer W., Kretzschmar H. A., McLean P. J., Trenkwalder C., Sarracino D. A., VonSattel J. P., Locascio J. J., El-Agnaf O. M. A., Schlossmacher M. G., Direct quantification of CSF -synuclein by ELISA and first cross-sectional study in patients with neurodegeneration Experimental Neurology 2008 213 2 315 325
71. Mukaetova-Ladinska E. B., Milne J., Andras A., Abdel-All Z., Cerejeira J., Greally E., Robson J., Jaros E., Perry R., McKeith I. G., Brayne C., Xuereb J., Cleghorn A., Doherty J., McIntosh G., Milton I., Alpha- and gamma-synuclein proteins are present in cerebrospinal fluid and are increased in aged subjects with neurodegenerative and vascular changes Dementia and Geriatric Cognitive Disorders 2008 26 1 32 42
72. Hong Z., Shi M., Chung K. A., Quinn J. F., Peskind E. R., Galasko D., Jankovic J., Zabetian C. P., Leverenz J. B., Baird G., Montine T. J., Hancock A. M., Hwang H., Pan C., Bradner J., Kang U. J., Jensen P. H., Zhang J., DJ-1 and -synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease Brain 2010 133 3 713 726
73. Ballard C., Jones E. L., Londos E., Minthon L., Francis P., Aarsland D., α-synuclein antibodies recognize a protein present at lower levels in the CSF of patients with dementia with Lewy bodies International Psychogeriatrics 2010 22 2 321 327
74. Tokuda T., Qureshi M. M., Ardah M. T., Varghese S., Shehab S. A.S., Kasai T., Ishigami N., Tamaoka A., Nakagawa M., El-Agnaf O. M.A., Detection of elevated levels of -synuclein oligomers in CSF from patients with Parkinson disease Neurology 2010 75 20 1766 1772
75. Li Q. X., Mok S. S., Laughton K. M., McLean C. A., Cappai R., Masters C. L., Culvenor J. G., Horne M. K., Plasma -synuclein is decreased in subjects with Parkinson's disease Experimental Neurology 2007 204 2 583 588 (Pubitemid 46497045)
76. El-Agnaf O. M. A., Salem S. A., Paleologou K. E., Curran M. D., Gibson M. J., Court J. A., Schlossmacher M. G., Allsop D., Detection of oligomeric forms of -synuclein protein in human plasma as a potential biomarker for Parkinson's disease Journal of the Federation of American Societies for Experimental Biology 2006 20 3 419 425 (Pubitemid 44933318)
77. Michell A. W., Luheshi L. M., Barker R. A., Skin and platelet -synuclein as peripheral biomarkers of Parkinson's disease Neuroscience Letters 2005 381 3 294 298 (Pubitemid 40719174)
78. Barbour R., Kling K., Anderson J. P., Banducci K., Cole T., Diep L., Fox M., Goldstein J. M., Soriano F., Seubert P., Chilcote T. J., Red blood cells are the major source of alpha-synuclein in blood Neurodegenerative Diseases 2008 5 2 55 59
79. Nagakubo D., Taira T., Kitaura H., Ikeda M., Tamai K., Iguchi-Ariga S. M. M., Ariga H., DJ-1, a novel oncogene which transforms mouse NIH3T3 cells in cooperation with ras Biochemical and Biophysical Research Communications 1997 231 2 509 513 (Pubitemid 27214343)
80. Shendelman S., Jonason A., Martinat C., Leete T., Abeliovich A., DJ-1 Is a redox-dependent molecular chaperone that inhibits -synuclein aggregate formation Public Library of Science, Biology 2004 2 11, article e362
81. Takahashi K., Taira T., Niki T., Seino C., Iguchi-Ariga S. M. M., Ariga H., DJ-1 positively regulates the androgen receptor by impairing the binding of PIASx to the receptor Journal of Biological Chemistry 2001 276 40 37556 37563
82. Shinbo Y., Niki T., Taira T., Ooe H., Takahashi-Niki K., Maita C., Seino C., Iguchi-Ariga S. M. M., Ariga H., Proper SUMO-1 conjugation is essential to DJ-1 to exert its full activities Cell Death and Differentiation 2006 13 1 96 108
83. Kim R. H., Smith P. D., Aleyasin H., Hayley S., Mount M. P., Pownall S., Wakeham A., You-Ten A. J., Kalia S. K., Horne P., Westaway D., Lozano A. M., Anisman H., Park D. S., Mak T. W., Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6- tetrahydropyrindine (MPTP) and oxidative stress Proceedings of the National Academy of Sciences of the United States of America 2005 102 14 5215 5220
84. Meulener M., Whitworth A. J., Armstrong-Gold C. E., Rizzu P., Heutink P., Wes P. D., Pallanck L. J., Bonini N. M., Drosophila DJ-1 mutants are selectively sensitive to environmental toxins associated with Parkinson's disease Current Biology 2005 15 17 1572 1577 (Pubitemid 41219597)
85. Bonifati V., Rizzu P., van Baren M. J., Schaap O., Breedveld G. J., Krieger E., Dekker M. C. J., Squitieri F., Ibanez P., Joosse M., Van Dongen J. W., Vanacore N., Van Swieten J. C., Brice A., Meco G., Van Duijn C. M., Oostra B. A., Heutink P., Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism Science 2003 299 5604 256 259 (Pubitemid 36131051)
86. Moore D. J., Zhang L., Dawson T. M., Dawson V. L., A missense mutation (L166P) in DJ-1, linked to familial Parkinson's disease, confers reduced protein stability and impairs homo-oligomerization Journal of Neurochemistry 2003 87 6 1558 1567 (Pubitemid 38020589)
87. Miller D. W., Ahmad R., Hague S., Baptista M. J., Canet-Aviles R., McLendon C., Carter D. M., Zhu P. P., Stadler J., Chandran J., Klinefelter G. R., Blackstone C., Cookson M. R., L166P mutant DJ-1, causative for recessive Parkinson's disease, is degraded through the ubiquitin-proteasome system Journal of Biological Chemistry 2003 278 38 36588 36595 (Pubitemid 37139990)
88. Arias Vsquez A., Sleegers K., Dekker M. C. J., Van Gool W. A., Van Swieten J. C., Aulchenko Y. S., Oostra B. A., Van Duijn C. M., A deletion in DJ-1 and the risk of dementiaa population-based survey Neuroscience Letters 2004 372 3 196 199 (Pubitemid 39470195)
89. Morris C. M., O'Brien K. K., Gibson A. M., Hardy J. A., Singleton A. B., Polymorphism in the human DJ-1 gene is not associated with sporadic dementia with Lewy bodies or Parkinson's disease Neuroscience Letters 2003 352 2 151 153 (Pubitemid 37415147)
90. Rizzu P., Hinkle D. A., Zhukareva V., Bonifati V., Severijnen L. A., Martinez D., Ravid R., Kamphorst W., Eberwine J. H., Lee V. M. Y., Trojanowski J. Q., Heutink P., DJ-1 colocalizes with tau inclusions: a link between parkinsonism and dementia Annals of Neurology 2004 55 1 113 118 (Pubitemid 38067368)
91. Wang Y., Chandran J. S., Cai H., Mattson M. P., DJ-1 is essential for long-term depression at hippocampal CA1 synapses NeuroMolecular Medicine 2008 10 1 40 45
92. Waragai M., Wei J., Fujita M., Nakai M., Ho G. J., Masliah E., Akatsu H., Yamada T., Hashimoto M., Increased level of DJ-1 in the cerebrospinal fluids of sporadic Parkinson's disease Biochemical and Biophysical Research Communications 2006 345 3 967 972 (Pubitemid 43776502)
93. Waragai M., Nakai M., Wei J., Fujita M., Mizuno H., Ho G., Masliah E., Akatsu H., Yokochi F., Hashimoto M., Plasma levels of DJ-1 as a possible marker for progression of sporadic Parkinson's disease Neuroscience Letters 2007 425 1 18 22 (Pubitemid 47410359)
94. Allard L., Burkhard P. R., Lescuyer P., Burgess J. A., Walter N., Hocnstrasser D. F., Sanchez J. C., PARK7 and nucleoside diphosphate kinase A as plasma markers for the early diagnosis of stroke Clinical Chemistry 2005 51 11 2043 2051 (Pubitemid 41532619)
95. Koide-Yoshida S., Niki T., Ueda M., Himeno S., Taira T., Iguchi-Ariga S. M., Ando Y., Ariga H., DJ-1 degrades transthyretin and an inactive form of DJ-1 is secreted in familial amyloidotic polyneuropathy International Journal of Molecular Medicine 2007 19 6 885 893
96. Liu H., Wang M., Li M., Wang D., Rao Q., Wang Y., Xu Z., Wang J., Expression and role of DJ-1 in leukemia Biochemical and Biophysical Research Communications 2008 375 3 477 483
97. Choi J., Sullards M. C., Olzmann J. A., Rees H. D., Weintraub S. T., Bostwick D. E., Gearing M., Levey A. I., Chin L. S., Li L., Oxidative damage of DJ-1 is linked to sporadic Parkinson and Alzheimer diseases Journal of Biological Chemistry 2006 281 16 10816 10824 (Pubitemid 43855504)
98. Sidransky E., Gaucher disease: complexity in a "simple" disorder Molecular Genetics and Metabolism 2004 83 12 6 15 (Pubitemid 39311276)
99. Goker-Alpan O., Schiffmann R., LaMarca M. E., Nussbaum R. L., McInerney-Leo A., Sidransky E., Parkinsonism among Gaucher disease carriers Journal of Medical Genetics 2004 41 12 937 940 (Pubitemid 40007255)
100. Halperin A., Elstein D., Zimran A., Increased incidence of Parkinson disease among relatives of patients with Gaucher disease Blood Cells, Molecules, and Diseases 2006 36 3 426 428 (Pubitemid 43776190)
101. Aharon-Peretz J., Badarny S., Rosenbaum H., Gershoni-Baruch R., Mutations in the glucocerebrosidase gene and Parkinson disease: phenotype-genotype correlation Neurology 2005 65 9 1460 1461 (Pubitemid 41552780)
102. Aharon-Peretz J., Rosenbaum H., Gershoni-Baruch R., Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews The New England Journal of Medicine 2004 351 19 1972 1977 (Pubitemid 39447138)
103. Lwin A., Orvisky E., Goker-Alpan O., LaMarca M. E., Sidransky E., Glucocerebrosidase mutations in subjects with parkinsonism Molecular Genetics and Metabolism 2004 81 1 70 73 (Pubitemid 38064435)
104. Gan-Or Z., Giladi N., Rozovski U., Shifrin C., Rosner S., Gurevich T., Bar-Shira A., Orr-Urtreger A., Genotype-phenotype correlations between GBA mutations and Parkinson disease risk and onset Neurology 2008 70 24 2277 2283
105. Sidransky E., Nalls M. A., Aasly J. O., Aharon-Peretz J., Annesi G., Barbosa E. R., Bar-Shira A., Berg D., Bras J., Brice A., Chen C. M., Clark L. N., Condroyer C., De Marco E. V., Drr A., Eblan M. J., Fahn S., Farrer M. J., Fung H. C., Gan-Or Z., Gasser T., Gershoni-Baruch R., Giladi N., Griffith A., Gurevich T., Januario C., Kropp P., Lang A. E., Lee-Chen G. J., Lesage S., Marder K., Mata I. F., Mirelman A., Mitsui J., Mizuta I., Nicoletti G., Oliveira C., Ottman R., Orr-Urtreger A., Pereira L. V., Quattrone A., Rogaeva E., Rolfs A., Rosenbaum H., Rozenberg R., Samii A., Samaddar T., Schulte C., Sharma M., Singleton A., Spitz M., Tan E. K., Tayebi N., Toda T., Troiano A. R., Tsuji S., Wittstock M., Wolfsberg T. G., Wu Y. R., Zabetian C. P., Zhao Y., Ziegler S. G., Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease The New England Journal of Medicine 2009 361 17 1651 1661
106. Neumann J., Bras J., Deas E., O'sullivan S. S., Parkkinen L., Lachmann R. H., Li A., Holton J., Guerreiro R., Paudel R., Segarane B., Singleton A., Lees A., Hardy J., Houlden H., Revesz T., Wood N. W., Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease Brain 2009 132 7 1783 1794
107. Gan-Or Z., Giladi N., Orr-Urtreger A., Differential phenotype in Parkinson's disease patients with severe versus mild GBA mutations Brain 2009 132 10, article e125
108. Clark L. N., Kartsaklis L. A., Gilbert R. W., Dorado B., Ross B. M., Kisselev S., Verbitsky M., Mejia-Santana H., Cote L. J., Andrews H., Vonsattel J. P., Fahn S., Mayeux R., Honig L. S., Marder K., Association of glucocerebrosidase mutations with dementia with Lewy bodies Archives of Neurology 2009 66 5 578 583
109. Goker-Alpan O., Giasson B. I., Eblan M. J., Nguyen J., Hurtig H. I., Lee V. M. Y., Trojanowski J. Q., Sidransky E., Glucocerebrosidase mutations are an important risk factor for Lewy body disorders Neurology 2006 67 5 908 910 (Pubitemid 44394221)
110. Alvarez-Erviti L., Rodriguez-Oroz M. C., Cooper J. M., Caballero C., Ferrer I., Obeso J. A., Schapira A. H.V., Chaperone-mediated autophagy markers in Parkinson disease brains Archives of Neurology 2010 67 12 1464 1472
111. Cuervo A. M., Stafanis L., Fredenburg R., Lansbury P. T., Sulzer D., Impaired degradation of mutant -synuclein by chaperone-mediated autophagy Science 2004 305 5688 1292 1295 (Pubitemid 39129234)
112. Mak S. K., McCormack A. L., Manning-Bog A. B., Cuervo A. M., Di Monte D. A., Lysosomal degradation of -synuclein in vivo Journal of Biological Chemistry 2010 285 18 13621 13629
113. Hruska K., Goker-Alpan O., Sidransky E., Gaucher disease and the synucleinopathies Journal of Biomedicine and Biotechnology 2006 2006 3
114. Wong K., Sidransky E., Verma A., Mixon T., Sandberg G. D., Wakefield L. K., Morrison A., Lwin A., Colegial C., Allman J. M., Schiffmann R., Neuropathology provides clues to the pathophysiology of Gaucher disease Molecular Genetics and Metabolism 2004 82 3 192 207 (Pubitemid 38952652)
115. Ron I., Rapaport D., Horowitz M., Interaction between parkin and mutant glucocerebrosidase variants: a possible link between Parkinson disease and Gaucher disease Human Molecular Genetics 2010 19 19 3771 3781
116. Migita M., Hamada H., Fujimura J., Watanabe A., Shimada T., Fukunaga Y., Glucocerebrosidase level in the cerebrospinal fluid during enzyme replacement therapyunsuccessful treatment of the neurological abnormality in type 2 Gaucher disease European Journal of Pediatrics 2003 162 78 524 525 (Pubitemid 36904282)
117. Balducci C., Pierguidi L., Persichetti E., Parnetti L., Sbaragli M., Tassi C., Orlacchio A., Calabresi P., Beccari T., Rossi A., Lysosomal hydrolases in cerebrospinal fluid from subjects with Parkinson's disease Movement Disorders 2007 22 10 1481 1484 (Pubitemid 47280636)
118. Parnetti L., Balducci C., Pierguidi L., De Carlo C., Peducci M., D'Amore C., Padiglioni C., Mastrocola S., Persichetti E., Paciotti S., Bellomo G., Tambasco N., Rossi A., Beccari T., Calabresi P., Cerebrospinal fluid -glucocerebrosidase activity is reduced in dementia with Lewy Bodies Neurobiology of Disease 2009 34 3 484 486
119. Ho G. J., Drego R., Hakimian E., Masliah E., Mechanisms of cell signaling and inflammation in Alzheimer's disease Current Drug TargetsInflammation and Allergy 2005 4 2 247 256 (Pubitemid 40873107)
120. Mattila K. M., Rinne J. O., Lehtimki T., Rytt M., Ahonen J. P., Hurme M., Association of an interleukin 1B gene polymorphism (-511) with Parkinson's disease in Finnish patients Journal of Medical Genetics 2002 39 6 400 402 (Pubitemid 34664972)
121. Wahner A. D., Sinsheimer J. S., Bronstein J. M., Ritz B., Inflammatory cytokine gene polymorphisms and increased risk of Parkinson disease Archives of Neurology 2007 64 6 836 840 (Pubitemid 46919838)
122. Nishimura M., Mizuta I., Mizuta E., Yamasaki S., Ohta M., Kuno S., Influence of interleukin-1 gene polymorphisms on age-at-onset of sporadic Parkinson's disease Neuroscience Letters 2000 284 12 73 76 (Pubitemid 30193202)
123. Su X., Maguire-Zeiss K. A., Giuliano R., Prifti L., Venkatesh K., Federoff H. J., Synuclein activates microglia in a model of Parkinson's disease Neurobiology of Aging 2008 29 11 1690 1701
124. Blum-Degena D., Mller T., Kuhn W., Gerlach M., Przuntek H., Riederer P., Interleukin-1 and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients Neuroscience Letters 1995 202 12 17 20
125. Mller T., Blum-Degen D., Przuntek H., Kuhn W., Interleukin-6 levels in cerebrospinal fluid inversely correlate to severity of Parkinson's disease Acta Neurologica Scandinavica 1998 98 2 142 144 (Pubitemid 28351288)
126. Mogi M., Harada M., Riederer P., Narabayashi H., Fujita K., Nagatsu T., Tumor necrosis factor- (TNF- ) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients Neuroscience Letters 1994 165 12 208 210
127. Chen H., O'Reilly E. J., Schwarzschild M. A., Ascherio A., Peripheral inflammatory biomarkers and risk of Parkinson's disease American Journal of Epidemiology 2008 167 1 90 95
128. Gmez-Tortosa E., Gonzalo I., Fanjul S., Sainz M. J., Cantarero S., Cemilln C., Garca Yébenes J., Del Ser T., Cerebrospinal fluid markers in dementia with Lewy bodies compared with Alzheimer disease Archives of Neurology 2003 60 9 1218 1222 (Pubitemid 37099626)
129. Liu Q., Xie F., Siedlak S. L., Nunomura A., Honda K., Moreira P. I., Zhua X., Smith M. A., Perry G., Neurofilament proteins in neurodegenerative diseases Cellular and Molecular Life Sciences 2004 61 24 3057 3075 (Pubitemid 40104581)
130. Lavedan C., Buchholtz S., Nussbaum R. L., Albin R. L., Polymeropoulos M. H., A mutation in the human neurofilament M gene in Parkinson's disease that suggests a role for the cytoskeleton in neuronal degeneration Neuroscience Letters 2002 322 1 57 61 (Pubitemid 34215030)
131. Schmidt M. L., Murray J., Lee V. M. Y., Hill W. D., Wertkin A., Trojanowski J. Q., Epitope map of neurofilament protein domains in cortical and peripheral nervous system Lewy bodies American Journal of Pathology 1991 139 1 53 65
132. Holmberg B., Rosengren L., Karlsson J. E., Johnels B., Increased cerebrospinal fluid levels of neurofilament protein in progressive supranuclear palsy and multiple-system atrophy compared with Parkinson's disease Movement Disorders 1998 13 1 70 77 (Pubitemid 28029855)
133. Tohgi H., Abe T., Hashiguchi K., Saheki M., Takahashi S., Remarkable reduction in acetylcholine concentration in the cerebrospinal fluid from patients with Alzheimer type dementia Neuroscience Letters 1994 177 12 139 142 (Pubitemid 24269449)
134. Welch M. J., Markham C. H., Jenden D. J., Acetylcholine and choline in cerebrospinal fluid of patients with Parkinson's disease and Huntington's chorea Journal of Neurology Neurosurgery and Psychiatry 1976 39 4 367 374
135. Shimada H., Hirano S., Shinotoh H., Aotsuka A., Sato K., Tanaka N., Ota T., Asahina M., Fukushi K., Kuwabara S., Hattori T., Suhara T., Irie T., Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET Neurology 2009 73 4 273 278
136. Lunardi G., Galati S., Tropepi D., Moschella V., Brusa L., Pierantozzi M., Stefani A., Rossi S., Fornai F., Fedele E., Stanzione P., Hainsworth A. H., Pisani A., Correlation between changes in CSF dopamine turnover and development of dyskinesia in Parkinson's disease Parkinsonism and Related Disorders 2009 15 5 383 389
137. Kanemaru K., Yamanouchi H., Assessment of CSF homovanillic acid levels distinguishes dementia with Lewy bodies from Alzheimer's disease Journal of Neurology 2002 249 8 1125 1126 (Pubitemid 35002246)
138. Hu X. S., Okamura N., Arai H., Higuchi M., Matsui T., Tashiro M., Shinkawa M., Itoh M., Ido T., Sasaki H., 18F-fluorodopa PET study of striatal dopamine uptake in the diagnosis of dementia with Lewy bodies Neurology 2000 55 10 1575 1577
139. Walker Z., Jaros E., Walker R. W. H., Lee L., Costa D. C., Livingston G., Ince P. G., Perry R., McKeith I., Katona C. L. E., Dementia with Lewy bodies: a comparison of clinical diagnosis, FP-CIT single photon emission computed tomography imaging and autopsy Journal of Neurology, Neurosurgery and Psychiatry 2007 78 11 1176 1181 (Pubitemid 350057277)
140. O'Brien J. T., Colloby S., Fenwick J., Williams E. D., Firbank M., Burn D., Aarsland D., McKeith I. G., Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies Archives of Neurology 2004 61 6 919 925 (Pubitemid 38747333)
141. McKeith I., O'Brien J., Walker Z., Tatsch K., Booij J., Darcourt J., Padovani A., Giubbini R., Bonuccelli U., Volterrani D., Holmes C., Kemp P., Tabet N., Meyer I., Reininger C., Sensitivity and specificity of dopamine transporter imaging with I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study The Lancet Neurology 2007 6 4 305 313 (Pubitemid 46367938)
142. Roselli F., Pisciotta N. M., Perneczky R., Pennelli M., Aniello M. S., De Caro M. F., Ferrannini E., Tartaglione B., Defazio G., Rubini G., Livrea P., Severity of neuropsychiatric symptoms and dopamine transporter levels in dementia with Lewy bodies: a 123I-FP-CIT SPECT study Movement Disorders 2009 24 14 2097 2103
143. Yoshita M., Taki J., Yamada M., A clinical role for [(123)I]MIBG myocardial scintigraphy in the distinction between dementia of the Alzheimer's-type and dementia with Lewy bodies Journal of Neurology Neurosurgery and Psychiatry 2001 71 5 583 588 (Pubitemid 33010570)
144. Wada-Isoe K., Kitayama M., Nakaso K., Nakashima K., Diagnostic markers for diagnosing dementia with Lewy bodies: CSF and MIBG cardiac scintigraphy study Journal of the Neurological Sciences 2007 260 12 33 37 (Pubitemid 47212190)
145. Watanabe H., Ieda T., Katayama T., Takeda A., Aiba I., Doyu M., Hirayama M., Sobue G., Cardiac (123)I-meta-iodobenzylguanidine (MIBG) uptake in dementia with Lewy bodies: comparison with Alzheimer's disease Journal of Neurology Neurosurgery and Psychiatry 2001 70 6 781 783 (Pubitemid 32554209)
146. Yoshita M., Taki J., Yokoyama K., Noguchi-Shinohara M., Matsumoto Y., Nakajima K., Yamada M., Value of 123I-MIBG radioactivity in the differential diagnosis of DLB from AD Neurology 2006 66 12 1850 1854 (Pubitemid 44049815)
147. Hanyu H., Shimizu S., Hirao K., Kanetaka H., Iwamoto T., Chikamori T., Usui Y., Yamashina A., Koizumi K., Abe K., Comparative value of brain perfusion SPECT and [(123)I]MIBG myocardial scintigraphy in distinguishing between dementia with Lewy bodies and Alzheimer's disease European Journal of Nuclear Medicine and Molecular Imaging 2006 33 3 248 253
148. Estorch M., Camacho V., Paredes P., Rivera E., Rodrguez-Revuelto A., Flotats A., Kulisevsky J., Carrio I., Cardiac (123)I-metaiodobenzylguanidine imaging allows early identification of dementia with Lewy bodies during life European Journal of Nuclear Medicine and Molecular Imaging 2008 35 9 1636 1641
149. Kobayashi S., Tateno M., Morii H., Utsumi K., Saito T., Decreased cardiac MIBG uptake, its correlation with clinical symptoms in dementia with Lewy bodies Psychiatry Research 2009 174 1 76 80
150. Watson R., Blamire A. M., O'Brien J. T., Magnetic resonance imaging in Lewy body dementias Dementia and Geriatric Cognitive Disorders 2009 28 6 493 506
151. Burton E. J., McKeith I. G., Burn D. J., Williams E. D., O'Brien J. T., Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls Brain 2004 127 4 791 800 (Pubitemid 38478524)
152. O'Brien J. T., Paling S., Barber R., Williams E. D., Ballard C., McKeith I. G., Gholkar A., Crum W. R., Rossor M. N., Fox N. C., Progressive brain atrophy on serial MRI in dementia with Lewy bodies, AD, and vascular dementia Neurology 2001 56 10 1386 1388 (Pubitemid 32455303)
153. Burton E. J., McKeith I. G., Burn D. J., O'Brien J. T., Brain atrophy rates in Parkinson's disease with and without dementia using serial magnetic resonance imaging Movement Disorders 2005 20 12 1571 1576
154. Sabattoli F., Boccardi M., Galluzzi S., Treves A., Thompson P. M., Frisoni G. B., Hippocampal shape differences in dementia with Lewy bodies NeuroImage 2008 41 3 699 705
155. Firbank M. J., Blamire A. M., Krishnan M. S., Teodorczuk A., English P., Gholkar A., Harrison R. M., O'Brien J. T., Diffusion tensor imaging in dementia with Lewy bodies and Alzheimer's disease Psychiatry Research 2007 155 2 135 145 (Pubitemid 46874916)
156. Lobotesis K., Fenwick J. D., Phipps A., Ryman A., Swann A., Ballard C., McKeith I. G., O'Brien J. T., Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD Neurology 2001 56 5 643 649 (Pubitemid 32209999)
157. Colloby S. J., Fenwick J. D., Williams D. E., Paling S. M., Lobotesis K., Ballard C., McKeith I., O'Brien J. T., A comparison of (99m)Tc-HMPAO SPET changes in dementia with Lewy bodies and Alzheimer's disease using statistical parametric mapping European Journal of Nuclear Medicine and Molecular Imaging 2002 29 5 615 622 (Pubitemid 34439321)
158. Hardy J., Lewis P., Revesz T., Lees A., Paisan-Ruiz C., The genetics of Parkinson's syndromes: a critical review Current Opinion in Genetics and Development 2009 19 3 254 265
159. MacLeod D., Dowman J., Hammond R., Leete T., Inoue K., Abeliovich A., The familial parkinsonism gene LRRK2 regulates neurite process morphology Neuron 2006 52 4 587 593 (Pubitemid 44781171)
160. Lin C. H., Tsai P. I., Wu R. M., Chien C. T., LRRK2 G2019S mutation induces dendrite degeneration through mislocalization and phosphorylation of tau by recruiting autoactivated GSK3 Journal of Neuroscience 2010 30 39 13138 13149
161. Melrose H. L., Dchsel J. C., Behrouz B., Lincoln S. J., Yue M., Hinkle K. M., Kent C. B., Korvatska E., Taylor J. P., Witten L., Liang Y. Q., Beevers J. E., Boules M., Dugger B. N., Serna V. A., Gaukhman A., Yu X., Castanedes-Casey M., Braithwaite A. T., Ogholikhan S., Yu N., Bass D., Tyndall G., Schellenberg G. D., Dickson D. W., Janus C., Farrer M. J., Impaired dopaminergic neurotransmission and microtubule-associated protein tau alterations in human LRRK2 transgenic mice Neurobiology of Disease 2010 40 3 503 517
162. Lin X., Parisiadou L., Gu X. L., Wang L., Shim H., Sun L., Xie C., Long C. X., Yang W. J., Ding J., Chen Z. Z., Gallant P. E., Tao-Cheng J. H., Rudow G., Troncoso J. C., Liu Z., Li Z., Cai H., Leucine-rich repeat kinase 2 regulates the progression of neuropathology induced by Parkinson's-disease- related mutant -synuclein Neuron 2009 64 6 807 827
163. Duka T., Duka V., Joyce J. N., Sidhu A., α-synuclein contributes to GSK-3-catalyzed tau phosphorylation in Parkinson's disease models Journal of the Federation of American Societies for Experimental Biology 2009 23 9 2820 2830
164. Zhu X., Babar A., Siedlak S. L., Yang Q., Ito G., Iwatsubo T., Smith M. A., Perry G., Chen S. G., LRRK2 in Parkinson's disease and dementia with Lewy bodies Molecular Neurodegeneration 2006 1 17
165. Qing H., Zhang Y., Deng Y., McGeer E. G., McGeer P. L., Lrrk2 interaction with -synuclein in diffuse Lewy body disease Biochemical and Biophysical Research Communications 2009 390 4 1229 1234
166. Simn-Snchez J., Schulte C., Bras J. M., Sharma M., Gibbs J. R., Berg D., Paisan-Ruiz C., Lichtner P., Scholz S. W., Hernandez D. G., Krger R., Federoff M., Klein C., Goate A., Perlmutter J., Bonin M., Nalls M. A., Illig T., Gieger C., Houlden H., Steffens M., Okun M. S., Racette B. A., Cookson M. R., Foote K. D., Fernandez H. H., Traynor B. J., Schreiber S., Arepalli S., Zonozi R., Gwinn K., Van Der Brug M., Lopez G., Chanock S. J., Schatzkin A., Park Y., Hollenbeck A., Gao J., Huang X., Wood N. W., Lorenz D., Deuschl G., Chen H., Riess O., Hardy J. A., Singleton A. B., Gasser T., Genome-wide association study reveals genetic risk underlying Parkinson's disease Nature Genetics 2009 41 12 1308 1312
167. Satake W., Nakabayashi Y., Mizuta I., Hirota Y., Ito C., Kubo M., Kawaguchi T., Tsunoda T., Watanabe M., Takeda A., Tomiyama H., Nakashima K., Hasegawa K., Obata F., Yoshikawa T., Kawakami H., Sakoda S., Yamamoto M., Hattori N., Murata M., Nakamura Y., Toda T., Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease Nature Genetics 2009 41 12 1303 1307
168. DiMauro S., Schon E. A., Mitochondrial respiratory-chain diseases The New England Journal of Medicine 2003 348 26 2656 2668 (Pubitemid 36741594)
169. Vives-Bauza C., Przedborski S., Mitophagy: the latest problem for Parkinson's disease Trends in Molecular Medicine 2011 17 3 158 165
170. Matsuda N., Sato S., Shiba K., Okatsu K., Saisho K., Gautier C. A., Sou Y. S., Saiki S., Kawajiri S., Sato F., Kimura M., Komatsu M., Hattori N., Tanaka K., PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy Journal of Cell Biology 2010 189 2 211 221
171. Narendra D. P., Jin S. M., Tanaka A., Suen D. F., Gautier C. A., Shen J., Cookson M. R., Youle R. J., PINK1 is selectively stabilized on impaired mitochondria to activate Parkin Public Library of Science, Biology 2010 8 1
172. Park J., Lee S. B., Lee S., Kim Y., Song S., Kim S., Bae E., Kim J., Shong M., Kim J. M., Chung J., Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin Nature 2006 441 7097 1157 1161 (Pubitemid 43990737)
173. Lee J. Y., Nagano Y., Taylor J. P., Lim K. L., Yao T. P., Disease-causing mutations in parkin impair mitochondrial ubiquitination, aggregation, and HDAC6-dependent mitophagy Journal of Cell Biology 2010 189 4 671 679
174. Wilhelmus M. M. M., Van Der Pol S. M. A., Jansen Q., Witte M. E., Van Der Valk P., Rozemuller A. J. M., Drukarch B., De Vries H. E., Van Horssen J., Association of Parkinson disease-related protein PINK1 with Alzheimer disease and multiple sclerosis brain lesions Free Radical Biology and Medicine 2011 50 3 469 476
175. Witte M. E., Bol J. G. J. M., Gerritsen W. H., Valk P. V. D., Drukarch B., Horssen J. V., Wilhelmus M. M. M., Parkinson's disease-associated parkin colocalizes with Alzheimer's disease and multiple sclerosis brain lesions Neurobiology of Disease 2009 36 3 445 452
176. Scherzer C. R., Jensen R. V., Gullans S. R., Feany M. B., Gene expression changes presage neurodegeneration in a Drosophila model of Parkinson's disease Human Molecular Genetics 2003 12 19 2457 2466 (Pubitemid 37220410)
177. Lu L., Neff F., Alvarez-Fischer D., Henze C., Xie Y., Oertel W. H., Schlegel J., Hartmann A., Gene expression profiling of Lewy body-bearing neurons in Parkinson's disease Experimental Neurology 2005 195 1 27 39 (Pubitemid 41116811)
178. Shi M., Caudle W. M., Zhang J., Biomarker discovery in neurodegenerative diseases: a proteomic approach Neurobiology of Disease 2009 35 2 157 164
179. Jin J., Meredith G. E., Chen L., Zhou Y., Xu J., Shie F. S., Lockhart P., Zhang J., Quantitative proteomic analysis of mitochondrial proteins: relevance to Lewy body formation and Parkinson's disease Molecular Brain Research 2005 134 1 119 138 (Pubitemid 40403644)
180. Basso M., Giraudo S., Corpillo D., Bergamasco B., Lopiano L., Fasano M., Proteome analysis of human substantia nigra in Parkinson's disease Proteomics 2004 4 12 3943 3952 (Pubitemid 39657469)
181. Shi M., Jin J., Wang Y., Beyer R. P., Kitsou E., Albin R. L., Gearing M., Pan C., Zhang J., Mortalin: a protein associated with progression of Parkinson disease? Journal of Neuropathology and Experimental Neurology 2008 67 2 117 124
182. Leverenz J. B., Umar I., Wang Q., Montine T. J., McMillan P. J., Tsuang D. W., Jin J., Pan C., Shin J., Zhu D., Zhang J., Proteomic identification of novel proteins in cortical Lewy bodies Brain Pathology 2007 17 2 139 145 (Pubitemid 46466133)
183. Abdi F., Quinn J. F., Jankovic J., McIntosh M., Leverenz J. B., Peskind E., Nixon R., Nutt J., Chung K., Zabetian C., Samii A., Lin M., Hattan S., Pan C., Wang Y., Jin J., Zhu D., Li G. J., Liu Y., Waichunas D., Montine T. J., Zhang J., Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders Journal of Alzheimer's Disease 2006 9 3 293 348 (Pubitemid 44253348)
184. Wada-Isoe K., Michio K., Imamura K., Nakaso K., Kusumi M., Kowa H., Nakashima K., Serum proteomic profiling of dementia with Lewy bodies: diagnostic potential of SELDI-TOF MS analysis Journal of Neural Transmission 2007 114 12 1579 1583 (Pubitemid 350212016)
185. Bianchi M. E., DAMPs, PAMPs and alarmins: all we need to know about danger Journal of Leukocyte Biology 2007 81 1 1 5 (Pubitemid 46028489)